Where is the Progress?;Wo ist der Fortschritt?

Psychiatrische Praxis

Volumn 39, Issue 2, 2012, Pages 55-56

  Priebe, Stefan ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; PSYCHIATRY;

ANTIPSYCHOTIC AGENTS; DAY CARE; FORECASTING; GERMANY; HUMANS; NEUROPSYCHIATRY; PATIENT CARE TEAM; PSYCHIATRY; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; QUALITY IMPROVEMENT; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME;

EID: 84856879565     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0031-1298907     Document Type: Editorial

References (6)

1. Bertelsen M, Jeppesen P, Petersen L et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry: 2008; 65 762 771 (Pubitemid 351957702)
2. Jones C, Hacker D, Meaden A et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev: 2011; 4 CD00524
3. Kemp AS, Schooler NR, Kalili AH et al. What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull: 2010; 36 504 509
4. Killaspy H, Bebbington P, Blizard P et al. The REACT study: randomised evaluation of assertive community treatment in north London. BMJ: 2006; 332 815 820
5. Burns T, Catty J, Watt H et al. International differences in home treatment for mental health problems: Results of a systematic review. Br J Psychiatry: 2002; 181 375 382 (Pubitemid 35333103)
6. Hrbjartsson A, Gtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med: 2001; 344 1594 1602